tiprankstipranks

Joseph Grano Insider Profile

4 Followers
Joseph Grano, Director at Aevi Genomic Medicine, holds 174.85K shares in Aevi Genomic Medicine (Ticker: GNMX), holds ― shares in Virtu Financial (Ticker: VIRT). Most recently, Joseph Grano Bought ― shares of Aevi Genomic Medicine on Nov 13, 2018 for an estimated value of 78.88K.
tipranks
Joseph Grano

Joseph Grano
Aevi Genomic Medicine (GNMX)
Director

Ranked #53,992 out of 78,624 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-12.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Joseph Grano does not currently own shares as a corporate insider.
A breakdown of Joseph Grano's holdings

Insider Roles

Virtu Financial
(VIRT)
Director
Roles that Joseph Grano holds in companies

Most Profitable Insider Trade

Stock:
Aevi Genomic Medicine
(GNMX)
Rating:Informative Buy
Date:Dec 01, 2014 - Dec 01, 2015
Return:+61.90%
The most profitable trade made by Joseph Grano

Joseph Grano's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GNMX
Aevi Genomic Medicine
Nov 13, 2018
Informative Buy
78.88K
$40.56K
Virtu Financial
Director
List of latest transactions for each holding click on a transaction to see Joseph Grano's performance on stock

Joseph Grano insider profile FAQ

What is the percentage of profitable transactions made by Joseph Grano?
The percentage of profitable transactions made by Joseph Grano is 50%.
    What is the average return per transaction made by Joseph Grano?
    The average return per transaction made by Joseph Grano is -12.90%.
      What stocks does Joseph Grano hold?
      Joseph Grano holds: GNMX, VIRT stocks.
        What was Joseph Grano’s latest transaction?
        Joseph Grano latest transaction was an Informative Buy of $78.88K.
          What was Joseph Grano's most profitable transaction?
          Joseph Grano’s most profitable transaction was an Informative Buy of GNMX stock on December 1, 2014. The return on the trade was 61.90%.
            What is Joseph Grano's role in Aevi Genomic Medicine?
            Joseph Grano's role in Aevi Genomic Medicine is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.